In recent decades, the prevalence of diabetes has risen dramatically worldwide; it is worth mentioning that diabetes affects more than 420 million people globally.

The conventional treatment approaches for diabetes management include lifestyle changes, oral therapeutics and insulin injections; however, these approaches have certain drawbacks such as painful and inconvenient procedures that often result in poor medication adherence. As a result, advanced insulin delivery systems, particularly insulin pumps, are increasingly being adopted as a sophisticated and patient-friendly solution. These devices are small, light-weight and deliver insulin either continuously or in controlled intervals, tailored to the patient's needs.

The insulin pump market size is projected to grow from $5.8 billion in 2024 to $13.6 billion by 2035, representing a CAGR of 8% during the forecast period till 2035.

The insulin pumps sector has several significant megatrends that shape its development and adoption, including rising popularity of patch pumps, integration with continuous glucose monitors (for automated insulin delivery), enhanced interoperability via smartphones and cloud-based systems (for data tracking and sharing with doctors/physicians), and employment of artificial intelligence and machine learning (for improved insulin dosing algorithms).

Insulin Pumps: Market Landscape

The current market landscape features the presence of over 40 insulin pumps that are currently available / under development. Most (over 85%) of the insulin pumps are currently available in the market / commercialized, demonstrating the maturity of industry and significant demand of consumers. It is worth mentioning that maximum number of the insulin pumps were launched post-2018; examples of recently launched pumps include (in alphabetical order) iLet ACE Pump (Beta Bionics, 2023), Kaleido (ViCentra, 2023) and Tandem Mobi System (Tandem Diabetes Care, 2024).

Additionally, patch pumps dominate the insulin pumps domain; these pumps directly adhere to the patients' skin (due to the presence of an adhesive backing) and deliver insulin into the body via a small tube (inserted into the skin). Some advantages of the patch pumps include discreetness (enables easy concealment under clothes), convenience (eliminating the requirement of additional infusion set components) and improved mobility (due to the absence of external tubing).

Around 80% of the insulin pumps are automated / smart pumps; these pumps allow automatic adjustment of insulin doses (based on real-time glucose information), integration with continuous glucose monitors (to offer precise insulin management) and compatibility with diabetes management software (to enable health data sharing with caregivers). In addition, smart pumps offer smartphone connectivity in order to effectively track the medication activity of patients; these pumps are beneficial for children or elderly users. Notably, over 10% of the insulin pumps are suitable for the delivery of insulin in patients suffering from Type 1 and Type 2 diabetes.

Insulin Pumps: Manufacturer Landscape

Dying our research, we identified 30 players that are engaged in manufacturing insulin pumps. The insulin pumps industry is well-fragmented, consisting of established companies and emerging enterprises competing in the market. Notably, around 20% of the companies were set up post-2012, indicating dynamic opportunities for innovation and growth in this sector.

Over 40% of the players in this domain are headquartered in North America, followed by companies headquartered in Europe and Asia-Pacific. In addition, 45% of the insulin pump manufacturers are large and very large firms.

Thank you for reading our report. Kindly get in touch with us to know more about the report or to receive a customized copy of it. Our team will ensure the report is tailored according to your needs. 

To view more details on this report, click on the link

https://www.rootsanalysis.***/reports/insulin-pump-market.html

About Roots Analysis

Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights.   

We specialize in analyzing areas which have lacked quality research so far or require more focused understanding within the broader industry. All our reports are structured in a way to enable the reader develop a thorough perspective on the given subject. Apart from writing reports on identified areas, we also provide bespoke research / consulting services dedicated to serve our clients in the best possible way.

The research efforts are driven by a global team. The leadership team brings a wealth of experience within the sector. Their collective experience in pharmaceutical / affiliated domains allows us to tackle various areas of research in a structured way. We also regularly leverage our global network of experts who hold senior leadership positions in reputed firms and organizations worldwide.

Contact:

Roots Analysis

Gaurav Chaudhary

+1 (415) 800 3415

+44 (122) 391 1091

Gaurav.chaudhary@rootsanalysis.***

Website: https://www.rootsanalysis.***/